Last reviewed · How we verify
NCT07589361
Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors
trial testing Vertebral Body-Sparing Craniospinal Proton Irradiation in Pediatric Central Nervous System Tumors in 38 participants. Not yet recruiting.
Quick facts
| Lead sponsor | Ruijin Hospital |
|---|---|
| Status | Not yet recruiting |
| Enrollment | 38 |
| Start date | 30 April 2026 |
| Estimated completion | 31 December 2033 |
Drugs / interventions tested
- Vertebral Body-Sparing Craniospinal Proton Irradiation
Conditions studied
- Pediatric Central Nervous System Tumors — all drugs for Pediatric Central Nervous System Tumors →
- Medulloblastoma — all drugs for Medulloblastoma →
- Germinoma — all drugs for Germinoma →
- Ependymoma — all drugs for Ependymoma →
Sponsor
Ruijin Hospital
Who can join
Eligibility, any sex, with Pediatric Central Nervous System Tumors or Medulloblastoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07589361
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ruijin Hospital trials
Trials by the same sponsor.
- NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
- NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
- NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
- NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting
- NCT07527689 — Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07589361 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
- Last refreshed: recently
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07589361.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing